Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy

Background and purpose Generalized myasthenia gravis (gMG) continues to present significant challenges for clinical management due to an unpredictable disease course, frequent disease fluctuations, and varying response to therapy. The recent availability of new pharmacologic therapies presents a val...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of neurology Vol. 31; no. 6; pp. e16180 - n/a
Main Authors:	Saccà, Francesco, Salort‐Campana, Emmanuelle, Jacob, Saiju, Cortés‐Vicente, Elena, Schneider‐Gold, Christiane
Format:	Journal Article
Language:	English
Published:	England John Wiley & Sons, Inc 01.06.2024
Subjects:	Algorithms Availability Biomarkers classification Cost of Illness Decision making disease burden generalized myasthenia gravis Health services Human motion Humans Immune system Immunosuppressive agents Myasthenia gravis Myasthenia Gravis - drug therapy Myasthenia Gravis - therapy Neuromuscular junctions pathophysiology Patients Quality of Life Social impact targeted therapy targeted therapy disease burden classification generalized myasthenia gravis pathophysiology
ISSN:	1351-5101, 1468-1331, 1468-1331
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!